Investment Research & Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,171
Closed -$90.2K 218
2023
Q2
$90.2K Hold
1,171
0.05% 83
2023
Q1
$88K Hold
1,171
0.06% 78
2022
Q4
$92.3K Hold
1,171
0.06% 77
2022
Q3
$82K Hold
1,171
0.06% 79
2022
Q2
$92K Hold
1,171
0.07% 82
2022
Q1
$89K Hold
1,171
0.06% 92
2021
Q4
$100K Hold
1,171
0.06% 81
2021
Q3
$89K Hold
1,171
0.06% 85
2021
Q2
$95K Hold
1,171
0.06% 92
2021
Q1
$92K Hold
1,171
0.07% 80
2020
Q4
$100K Hold
1,171
0.07% 73
2020
Q3
$90K Hold
1,171
0.07% 74
2020
Q2
$85K Hold
1,171
0.08% 72
2020
Q1
$78K Hold
1,171
0.07% 71
2019
Q4
$81K Buy
+1,171
New +$79.8K 0.07% 80

Other funds holding CL

Investment Research & Advisory Group's CL Position: Q3 2023 in Review

Investment Research & Advisory Group sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 1,171 shares — an estimated $90.2K sold.

Investment Research & Advisory Group first reported a position in CL in Q4 2019 and held it in 15 quarters. The position peaked at $100K in Q4 2021. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Investment Research & Advisory Group reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Investment Research & Advisory Group sold 1,171 Colgate-Palmolive shares in Q3 2023, an estimated $90.2K.
  • Investment Research & Advisory Group first reported a position in Colgate-Palmolive in Q4 2019 and held it in 15 quarters.
  • Investment Research & Advisory Group's Colgate-Palmolive position peaked at $100K in Q4 2021.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Investment Research & Advisory Group's 13F filing for Q3 2023, filed 19 Oct 2023.